-
Molecular Pathology v. Myriad Genetics: The Implications of the Supreme Court Decision
$175In Molecular Pathology v. Myriad Genetics, the Supreme Court held that isolated DNA is not patent-eligible subject matter, but that cDNA may be patent-eligible subject matter under certain circumstances. This webinar discusses the extent to which additional limitations may be placed on the patentability of biotechnology claims. Among…
-
Navigating Ethical Issues in Patent Prosecution
$175This session discusses a multitude of ethical issues that arise during the prosecution of patents. Examples are provided that illustrate the range of severity of prosecutorial negligence as well as the resulting disciplinary action taken against the counselor. A review of critical litigation between prosecuting patent attorneys and…
-
Negotiating License Agreements with Start-Ups
$175Licensing negotiations between large licensees and start-ups are wildly asymmetric. Large companies conduct scores of such negotiations every year, while the typical start-up may never have engaged in the process. Large licensees benefit from robust teams of highly skilled lawyers, technical experts, finance professionals, and dedicated negotiators, while…
-
Negotiating Patent and Technology License Agreements
$295Patent and trade secret licensing agreements can be both exhaustive and highly nuanced, with thousands of possible permutations. Understanding the intricacies of licensing agreements is imperative for both licensors and licensees. Overlooking even one facet of these agreements can be ruinous to inventors and commercializers. This top-notch webinar…
-
Negotiating Patent Infringement Indemnification
$175Manufacturers and their suppliers are often confronted with the issue of patent infringement indemnification. Failure to consider a range of issues that could arise with respect to allegations of patent infringement at the outset of a business relationship can present ruinous liabilities for suppliers and end producers. This…
